INHIBITOR THERAPTICS INC (INTI) SEC filings

INTI SEC filings moved a median of -0.40% by the close. INTI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the INTI overview →

17 measured INTI SEC filing events.

Where these INTI SEC filings landedvs 11 measured INTI SEC filing reactions
INTI SEC filingMiddle 50% · -5.35% to +9.21%Zero: 0.00%Median: -0.40%Median -0.40%-15.00%0+15.00%
Middle 50% of INTI SEC filing reactions-5.35% to +9.21%
Median reaction (to close)-0.40%
Measured reactions11
Point-in-time · zero look-ahead

Half of the 11 INTI SEC filing events with a measured close landed between -5.35% and +9.21%; 27% closed up.

DateHeadlineEvent5-minTo close
Form 8-K Inhibitor Therapeutics, For: Sep 15SEC filing · Form 8-K——
Form DEF 14A Inhibitor Therapeutics, For: Aug 17SEC filing · Form DEF+0.00%-1.11%
Form 10-Q Inhibitor Therapeutics, For: Jun 30SEC filing · Form 10-Q+0.00%-1.11%
Form 10-Q Inhibitor Therapeutics, For: Mar 31SEC filing · Form 10-Q——
Form 8-K Inhibitor Therapeutics, For: Apr 01SEC filing · Form 8-K——
Form 10-K Inhibitor Therapeutics, For: Dec 31SEC filing · Form 10-K-10.00%-10.00%
Form 8-K Inhibitor Therapeutics, For: Feb 24SEC filing · Form 8-K+1.97%+18.42%
Form 10-Q Inhibitor Therapeutics, For: Sep 30SEC filing · Form 10-Q——
Form 8-K Inhibitor Therapeutics, For: Oct 24SEC filing · Form 8-K-0.40%-0.40%
Form 10-Q Inhibitor Therapeutics, For: Jun 30SEC filing · Form 10-Q+0.00%+0.00%
Form 10-Q Inhibitor Therapeutics, For: Mar 31SEC filing · Form 10-Q+0.00%+77.37%
Form 10-K Inhibitor Therapeutics, For: Dec 31SEC filing · Form 10-K-9.58%-9.58%
Form 10-Q Inhibitor Therapeutics, For: Sep 30SEC filing · Form 10-Q——
Form 10-Q Inhibitor Therapeutics, For: Jun 30SEC filing · Form 10-Q——
Form 10-Q Inhibitor Therapeutics, For: Mar 31SEC filing · Form 10-Q+0.00%+0.00%
Form 10-K Inhibitor Therapeutics, For: Dec 31SEC filing · Form 10-K+0.00%-12.10%
Form 8-K Inhibitor Therapeutics, For: Dec 12SEC filing · Form 8-K+13.11%+24.59%
That’s how INTI usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More INTI: earnings → · analyst actions → · INTI overview →